Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Canopy Growth Corp(CGC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CGC
11/03/2026: CGC (1-star) is currently NOT-A-BUY. Pass it for now.
Canopy Growth Corp is a leading Canadian cannabis company that has transitioned from aggressive growth to a more focused, profitability-driven strategy. The company benefits from a strategic partnership with Constellation Brands and a diverse product portfolio, though it faces substantial challenges, including a history of net losses and intense market competition. Its primary growth story revolves around the eventual opening of the U.S. market via its Canopy USA structure. However, investors must weigh this against significant execution, valuation, and regulatory risks. The stock is generally suited for those with a high risk tolerance who are looking for long-term exposure to the potential legalization of cannabis in the United States.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The company is currently in a restructuring phase focused on profitability rather than aggressive expansion. |
| Momentum investor | Weak fit | The stock has experienced significant downward pressure, and a positive upturn signal would be required to consider this style. |
| Value investor | Weak fit | Valuation remains difficult to support given the lack of consistent earnings and ongoing operational challenges. |
| Dividend investor | Weak fit | The company does not pay a dividend and is focused on capital preservation. |
| Low-risk investor | Weak fit | High volatility and industry-specific regulatory risks make this unsuitable for conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock price is subject to extreme swings based on regulatory news and market sentiment. |
| Valuation risk | High | Valuations in the cannabis sector remain disconnected from traditional fundamentals. |
| Competition risk (cannabis producers) | High | Intense competition from peers like Tilray pressures margins and market share. |
| Business quality | Medium | The business is transitioning, but historical profitability remains elusive. |
| Dividend income | Low / none | There is no dividend income available for investors. |
| Execution risk | High | The company faces significant challenges in executing its U.S. strategy and achieving sustained profitability. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -61.98% | Avg. Invested days 8 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/03/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 305.88M USD | Price to earnings Ratio - | 1Y Target Price 0.92 |
Price to earnings Ratio - | 1Y Target Price 0.92 | ||
Volume (30-day avg) 2.3M shares | Beta 2.44 | 52 Weeks Range 0.64 - 2.38 | Updated Date 11/02/2026 |
52 Weeks Range 0.64 - 2.38 | Updated Date 11/02/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.45 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Recreational Cannabis | Sale of Tweed and other brand cannabis products to Canadian adult-use consumers. | This is the primary revenue driver, but it faces tough competition and pricing pressure. |
| Medical Cannabis | Cannabis products for medical patients in Canada and other international markets. | A more stable but generally slower-growing segment compared to the recreational market. |
| Geography: North America | Operations primarily in Canada, with options for future U.S. expansion via Canopy USA. | Future potential hinges on U.S. federal regulatory changes. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 20.37 | Enterprise Value 238.88M | Price to Sales(TTM) 1.04 |
Enterprise Value 238.88M | Price to Sales(TTM) 1.04 | ||
Enterprise Value to Revenue 1.14 | Enterprise Value to EBITDA 11014.1 | Shares Outstanding 423.04M | Shares Floating 422.10M |
Shares Outstanding 423.04M | Shares Floating 422.10M | ||
Percent Insiders 0.18 | Percent Institutions 7.76 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.